AI Diagnostics Hit Critical Mass as Hospitals Race to Cut Costs [Globe and Mail, The (Toronto, Canada)]
Heartflow, Inc. (HTFL)
Company Research
Source: Globe and Mail, The
infectious disease diagnostics valued at $53 billion in 2024 are projected to nearly double by 2033, driven by AI systems that deliver laboratory-grade results at the bedside [1] . Meanwhile, healthcare organizations implementing domain-specific AI tools surged 7x in 2025 as financial pressure mounts, with hospital expenses rising 6% annually while revenue grows just 3% [2] . Five publicly traded companies are positioned at the center of this shift, each holding FDA clearance for AI systems that eliminate diagnostic delays and transform patient management at the point of care: VentriPoint Diagnostics (TSXV: VPT ) (OTCPK: VPTDF), Heartflow, Inc. (NASDAQ: HTFL), CeriBell, Inc. (NASDAQ: CBLL), Medtronic plc (NYSE: MDT), and Abbott Laboratories (NYSE: ABT). Read more at newswire.ca This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view th
Show less
Read more
Impact Snapshot
Event Time:
HTFL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HTFL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HTFL alerts
High impacting Heartflow, Inc. news events
Weekly update
A roundup of the hottest topics
HTFL
News
- Heartflow Plaque Analysis Now Supported by Scientific Statements From American College of Cardiology and American Heart Association for Personalized Management of Patients with Suspected CAD [Yahoo! Finance]Yahoo! Finance
- Heartflow Plaque Analysis Now Supported by Scientific Statements From American College of Cardiology and American Heart Association for Personalized Management of Patients with Suspected CADGlobeNewswire
- Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery DiseaseGlobeNewswire
- Heartflow to Participate in the Piper Sandler 37th Annual Healthcare ConferenceGlobeNewswire
- Heartflow (NASDAQ:HTFL) had its price target raised by analysts at Canaccord Genuity Group Inc. from $39.00 to $40.00. They now have a "buy" rating on the stock.MarketBeat
HTFL
Earnings
- 11/12/25 - In-Line
HTFL
Sec Filings
- 12/17/25 - Form 4
- 11/12/25 - Form 4
- 11/12/25 - Form 4
- HTFL's page on the SEC website